CPCurtis J. Pritzl

Curtis J. Pritzl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Curtis J. Pritzl has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    IKK2/NFkB signaling controls lung resident CD8+ T cell memory during influenza infection

    by Curtis J. Pritzl, Dezzarae Luera, Karin M. Knudson, Michael J. Quaney, Michael J. Calcutt, Mark A. Daniels, Emma Teixeiro

    CD8+ T cell tissue resident memory (TRM) cells are especially suited to control pathogen spread at mucosal sites. However, their maintenance in lung is short-lived. TCR-dependent NFkB signaling is crucial for T cell memory but how and when NFkB signaling modulates tissue resident and circulating T cell memory during the immune response is unknown. Here, we find that enhancing NFkB signaling in T cells once memory to influenza is established, increases pro-survival Bcl-2 and CD122 levels thus boosting lung CD8+ TRM maintenance. By contrast, enhancing NFkB signals during the contraction phase of the response leads to a defect in CD8+ TRM differentiation without impairing recirculating memory subsets. Specifically, inducible activation of NFkB via constitutive active IKK2 or TNF interferes with TGFβ signaling, resulting in defects of lung CD8+ TRM imprinting molecules CD69, CD103, Runx3 and Eomes. Conversely, inhibiting NFkB signals not only recovers but improves the transcriptional signature and generation of lung CD8+ TRM. Thus, NFkB signaling is a critical regulator of tissue resident memory, whose levels can be tuned at specific times during infection to boost lung CD8+ TRM.


  • Open Access

    STING controls T cell memory fitness during infection through T cell-intrinsic and IDO-dependent mechanisms

    by Michael J. Quaney, Curtis J. Pritzl, Dezzarae Luera, Rebecca J. Newth, Karin M. Knudson, Vikas Saxena, Caitlyn Guldenpfennig, Diana Gil, Chris S. Rae, Peter Lauer, et al.

    Stimulator of interferon genes (STING) signaling has been extensively studied in inflammatory diseases and cancer, while its role in T cell responses to infection is unclear. Using Listeria monocytogenes strains engineered to induce different levels of c-di-AMP, we found that high STING signals impaired T cell memory upon infection via increased Bim levels and apoptosis. Unexpectedly, reduction of TCR signal strength or T cell-STING expression decreased Bim expression, T cell apoptosis, and recovered T cell memory. We found that TCR signal intensity coupled STING signal strength to the unfolded protein response (UPR) and T cell survival. Under strong STING signaling, Indoleamine-pyrrole 2,3-dioxygenase (IDO) inhibition also reduced apoptosis and led to a recovery of T cell memory in STING sufficient CD8 T cells. Thus, STING signaling regulates CD8 T cell memory fitness through both cell-intrinsic and extrinsic mechanisms. These studies provide insight into how IDO and STING therapies could improve long-term T cell protective immunity.


  • Open Access

    Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistence

    by Caleb J. Studstill, Curtis J. Pritzl, Young-Jin Seo, Dae Young Kim, Chuan Xia, Jennifer J. Wolf, Ravi Nistala, Madhuvanthi Vijayan, Yong-Bin Cho, Kyung Won Kang, et al.

    Chronic viral infections are often established by the exploitation of immune regulatory mechanisms that result in non-functional T cell responses. Viruses that establish persistent infections remain a serious threat to human health. Sphingosine kinase (SphK) 2 generates sphingosine 1-phosphate, which is a molecule known to regulate multiple cellular processes. However, little is known about SphK2’s role during the host immune responses to viral infection. Here, we demonstrate that SphK2 functions during lymphocytic choriomeningitis virus Cl 13 (LCMV Cl 13) infection to limit T cell immune pathology, which subsequently aids in the establishment of virus-induced immunosuppression and the resultant viral persistence. The infection of Sphk2-deficient (Sphk2-/-) mice with LCMV Cl 13 led to the development of nephropathy and mortality via T cell-mediated immunopathology. Following LCMV infection, Sphk2-/- CD4+ T cells displayed increased activity and proliferation, and these cells promoted overactive LCMV Cl 13-specific CD8+ T cell responses. Notably, oral instillation of an SphK2-selective inhibitor promoted protective T cell responses and accelerated the termination of LCMV Cl 13 persistence in mice. Thus, SphK2 is indicated as an immunotherapeutic target for the control of persistent viral infections.


  • NFκB–Pim-1–Eomesodermin axis is critical for maintaining CD8 T-cell memory quality

    by Karin M. Knudson, Curtis J. Pritzl, Vikas Saxena, Amnon Altman, Mark A. Daniels, Emma Teixeiro

    Significance: Mice and humans whose T cells are deficient in NFκB signaling lack memory T cells, but the mechanism behind this is unclear. We found that NFκB signaling is required during the resolution phase of the immune response to maintain long-term CD8 memory. NFκB signaling is necessary for preserving expression of Eomesodermin and prosurvival Bcl-2 in memory T cells, in a cell-intrinsic process where T-cell receptor (TCR) signals and Pim-1 kinase are involved. Our study defines an unexpected role of NFκB and Pim-1 signaling in the maintenance of T-cell memory quality. Furthermore, it identifies targets and specific times of intervention where protective T-cell memory could be reinforced in vaccines and cancer immunotherapies by manipulation of the NFκB–Pim-1–Eomesodermin axis.